| 000 | 02479 a2200673 4500 | ||
|---|---|---|---|
| 005 | 20250514205008.0 | ||
| 264 | 0 | _c20050527 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a1524-4571 | ||
| 024 | 7 |
_a10.1161/01.RES.0000147557.75257.ff _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlcendor, Ralph R | |
| 245 | 0 | 0 |
_aSilent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. _h[electronic resource] |
| 260 |
_bCirculation research _cNov 2004 |
||
| 300 |
_a971-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcetylation _xdrug effects |
| 650 | 0 | 4 | _aAlkaloids |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aAtrial Natriuretic Factor _xbiosynthesis |
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 | _aBenzophenanthridines |
| 650 | 0 | 4 |
_aCell Nucleus _xenzymology |
| 650 | 0 | 4 |
_aCell Size _xdrug effects |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 |
_aCells, Cultured _xcytology |
| 650 | 0 | 4 | _aCulture Media, Serum-Free |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aGene Silencing _xphysiology |
| 650 | 0 | 4 | _aGenes, Dominant |
| 650 | 0 | 4 | _aGenes, p53 |
| 650 | 0 | 4 |
_aHeart Failure _xenzymology |
| 650 | 0 | 4 |
_aHeart Ventricles _xcytology |
| 650 | 0 | 4 |
_aHydroxamic Acids _xpharmacology |
| 650 | 0 | 4 | _aHypertrophy |
| 650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xenzymology |
| 650 | 0 | 4 |
_aLongevity _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xcytology |
| 650 | 0 | 4 |
_aNaphthols _xpharmacology |
| 650 | 0 | 4 |
_aNiacinamide _xpharmacology |
| 650 | 0 | 4 |
_aPhenanthridines _xpharmacology |
| 650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xphysiology |
| 650 | 0 | 4 | _aSirtuin 1 |
| 650 | 0 | 4 |
_aSirtuins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xphysiology |
| 700 | 1 | _aKirshenbaum, Lorrie A | |
| 700 | 1 | _aImai, Shin-ichiro | |
| 700 | 1 | _aVatner, Stephen F | |
| 700 | 1 | _aSadoshima, Junichi | |
| 773 | 0 |
_tCirculation research _gvol. 95 _gno. 10 _gp. 971-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.RES.0000147557.75257.ff _zAvailable from publisher's website |
| 999 |
_c15176573 _d15176573 |
||